Search

Khatol S. Shahnan Shah

Examiner (ID: 17930, Phone: (571)272-0863 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
691
Issued Applications
342
Pending Applications
101
Abandoned Applications
266

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9875543 [patent_doc_number] => 08962812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Methods of extracting chemical compounds from organisms with resistant cell walls' [patent_app_type] => utility [patent_app_number] => 13/655925 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2765 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655925 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/655925
Methods of extracting chemical compounds from organisms with resistant cell walls Oct 18, 2012 Issued
Array ( [id] => 9777396 [patent_doc_number] => 08852596 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-10-07 [patent_title] => 'Detection of Giardia lamblia trophozoites and cysts and protection against G. lamblia infection' [patent_app_type] => utility [patent_app_number] => 13/651830 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8586 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651830 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/651830
Detection of Giardia lamblia trophozoites and cysts and protection against G. lamblia infection Oct 14, 2012 Issued
Array ( [id] => 9771794 [patent_doc_number] => 20140295457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN' [patent_app_type] => utility [patent_app_number] => 14/351255 [patent_app_country] => US [patent_app_date] => 2012-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28843 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351255 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/351255
Gene cluster for biosynthesis of griselimycin and methylgriselimycin Oct 10, 2012 Issued
Array ( [id] => 9670462 [patent_doc_number] => 20140234325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'ADJUVANT THERAPY FOR STAPHYLOCOCCAL INFECTION WITH ENTEROTOXIN SPECIFIC MABS' [patent_app_type] => utility [patent_app_number] => 14/346981 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23906 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346981 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/346981
ADJUVANT THERAPY FOR STAPHYLOCOCCAL INFECTION WITH ENTEROTOXIN SPECIFIC MABS Sep 25, 2012 Abandoned
Array ( [id] => 12008650 [patent_doc_number] => 09801948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Antimicrobial compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/343809 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 27246 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343809 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/343809
Antimicrobial compositions and methods of use thereof Sep 20, 2012 Issued
Array ( [id] => 15756203 [patent_doc_number] => 10620205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-14 [patent_title] => NMR methods for endotoxin analysis [patent_app_type] => utility [patent_app_number] => 14/345803 [patent_app_country] => US [patent_app_date] => 2012-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10470 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345803 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/345803
NMR methods for endotoxin analysis Sep 19, 2012 Issued
Array ( [id] => 11928662 [patent_doc_number] => 09795640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance' [patent_app_type] => utility [patent_app_number] => 14/345906 [patent_app_country] => US [patent_app_date] => 2012-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 12426 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345906 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/345906
Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance Sep 18, 2012 Issued
Array ( [id] => 10219460 [patent_doc_number] => 20150104454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'ANTI-C.DIFFICILE TOXIN ANTIBODIES AND ASSOCIATED METHODS' [patent_app_type] => utility [patent_app_number] => 14/344749 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2442 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344749 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344749
Anti-C. difficile toxin antibodies and associated methods Sep 12, 2012 Issued
Array ( [id] => 10933345 [patent_doc_number] => 20140336366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'BIOCONJUGATE VACCINES MADE IN PROKARYOTIC CELLS' [patent_app_type] => utility [patent_app_number] => 14/342958 [patent_app_country] => US [patent_app_date] => 2012-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 15471 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342958 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/342958
BIOCONJUGATE VACCINES MADE IN PROKARYOTIC CELLS Sep 5, 2012 Abandoned
Array ( [id] => 10932519 [patent_doc_number] => 20140335540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS' [patent_app_type] => utility [patent_app_number] => 14/238451 [patent_app_country] => US [patent_app_date] => 2012-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7797 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238451 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/238451
METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS Aug 12, 2012 Abandoned
Array ( [id] => 10932519 [patent_doc_number] => 20140335540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS' [patent_app_type] => utility [patent_app_number] => 14/238451 [patent_app_country] => US [patent_app_date] => 2012-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7797 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238451 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/238451
METHOD OF DIAGNOSING BACTERIAL INFECTIONS USING BACTERIAL GLYCOPROTEINS Aug 12, 2012 Abandoned
Array ( [id] => 11304803 [patent_doc_number] => 09512189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Optimized antigens of pneumocystis and use thereof' [patent_app_type] => utility [patent_app_number] => 14/237133 [patent_app_country] => US [patent_app_date] => 2012-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 15194 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237133 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/237133
Optimized antigens of pneumocystis and use thereof Aug 5, 2012 Issued
Array ( [id] => 9785263 [patent_doc_number] => 20140302084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'IMMUNOGENIC PROTEIN CONJUGATES AND METHOD FOR MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/237320 [patent_app_country] => US [patent_app_date] => 2012-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11894 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237320 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/237320
IMMUNOGENIC PROTEIN CONJUGATES AND METHOD FOR MAKING AND USING THE SAME Aug 4, 2012 Abandoned
Array ( [id] => 9560600 [patent_doc_number] => 20140178313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR ORAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/236849 [patent_app_country] => US [patent_app_date] => 2012-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15545 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236849 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/236849
Prophylactic or therapeutic agent for oral diseases Aug 2, 2012 Issued
Array ( [id] => 11217802 [patent_doc_number] => 09446122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens' [patent_app_type] => utility [patent_app_number] => 14/234983 [patent_app_country] => US [patent_app_date] => 2012-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 7328 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234983 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/234983
Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens Jul 27, 2012 Issued
Array ( [id] => 9756258 [patent_doc_number] => 20140286960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'STAPHLOCOCCUS AUREUS ALPHA-HEMOLYSIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/235315 [patent_app_country] => US [patent_app_date] => 2012-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13001 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235315 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/235315
STAPHLOCOCCUS AUREUS ALPHA-HEMOLYSIN ANTIBODIES Jul 26, 2012 Abandoned
Array ( [id] => 9735936 [patent_doc_number] => 20140271649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING STAPHYLOCOCCUS AGGLUTINATION IN BLOOD' [patent_app_type] => utility [patent_app_number] => 14/233109 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22858 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233109 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/233109
METHODS AND COMPOSITIONS FOR INHIBITING STAPHYLOCOCCUS AGGLUTINATION IN BLOOD Jul 12, 2012 Abandoned
Array ( [id] => 8515850 [patent_doc_number] => 20120315258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'BACILLUS STRAINS AND METHODS FOR REDUCING E. COLI DISEASE AND ENHANCING PERFORMANCE' [patent_app_type] => utility [patent_app_number] => 13/494468 [patent_app_country] => US [patent_app_date] => 2012-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17641 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13494468 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/494468
Bacillus strains and methods for reducing E. coli disease and enhancing performance Jun 11, 2012 Issued
Array ( [id] => 9597196 [patent_doc_number] => 20140193876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN' [patent_app_type] => utility [patent_app_number] => 14/125695 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14803 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125695 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/125695
METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN Jun 7, 2012 Abandoned
Array ( [id] => 8509188 [patent_doc_number] => 20120308596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'NOVEL STREPTOCOCCUS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 13/491088 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 16032 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491088 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/491088
NOVEL STREPTOCOCCUS ANTIGENS Jun 6, 2012 Abandoned
Menu